These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 18393946)

  • 1. Hepatitis G virus: a suitable marker of in vivo efficacy for pathogen inactivation.
    Lefrère JJ; Laperche S; Roudot-Thoraval F
    Vox Sang; 2008 Jul; 95(1):76-8. PubMed ID: 18393946
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical trials for pathogen reduction in transfusion medicine: a review.
    McClaskey J; Xu M; Snyder EL; Tormey CA
    Transfus Apher Sci; 2009 Dec; 41(3):217-25. PubMed ID: 19793679
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence and trends of human immunodeficiency virus, hepatitis B virus, and hepatitis C virus among blood donors in Iran, 2004 through 2007.
    Kafi-abad SA; Rezvan H; Abolghasemi H; Talebian A
    Transfusion; 2009 Oct; 49(10):2214-20. PubMed ID: 19527477
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatitis G virus infection in multitransfused Egyptian children.
    Salama KM; Selim Oel-S
    Pediatr Hematol Oncol; 2009 Jun; 26(4):232-9. PubMed ID: 19437325
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence and risk factors of hepatitis C virus, hepatitis B virus, and human immunodeficiency virus in multiply transfused recipients in Mexico.
    Calderón GM; González-Velázquez F; González-Bonilla CR; Novelo-Garza B; Terrazas JJ; Martínez-Rodríguez ML; Cortés-Márquez SR; Blanco-Flores JP; Rodríguez-Rodríguez A; Del Campo MA; Cortés-Gómez R; Mejía-Bocanegra MG
    Transfusion; 2009 Oct; 49(10):2200-7. PubMed ID: 19538543
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of individual-donation nucleic acid testing on risk of human immunodeficiency virus, hepatitis B virus, and hepatitis C virus transmission by blood transfusion in South Africa.
    Vermeulen M; Lelie N; Sykes W; Crookes R; Swanevelder J; Gaggia L; Le Roux M; Kuun E; Gulube S; Reddy R
    Transfusion; 2009 Jun; 49(6):1115-25. PubMed ID: 19309474
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Trends in prevalence of hepatitis B virus infection among Iranian blood donors, 1998-2007.
    Kafi-abad SA; Rezvan H; Abolghasemi H
    Transfus Med; 2009 Aug; 19(4):189-94. PubMed ID: 19708860
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-HBs positive occult hepatitis B virus carrier blood infectious in two transfusion recipients.
    Levicnik-Stezinar S; Rahne-Potokar U; Candotti D; Lelie N; Allain JP
    J Hepatol; 2008 Jun; 48(6):1022-5. PubMed ID: 18436328
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lack of de novo hepatitis C virus infections and absence of nosocomial transmissions of GB virus C in a large cohort of German haemodialysis patients.
    Ross RS; Viazov S; Clauberg R; Wolters B; Fengler I; Eveld K; Scheidhauer R; Hüsing J; Philipp T; Kribben A; Roggendorf M
    J Viral Hepat; 2009 Apr; 16(4):230-8. PubMed ID: 19175869
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A case of transfusion-transmitted hepatitis E caused by blood from a donor infected with hepatitis E virus via zoonotic food-borne route.
    Matsubayashi K; Kang JH; Sakata H; Takahashi K; Shindo M; Kato M; Sato S; Kato T; Nishimori H; Tsuji K; Maguchi H; Yoshida J; Maekubo H; Mishiro S; Ikeda H
    Transfusion; 2008 Jul; 48(7):1368-75. PubMed ID: 18651907
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Pathogen inactivation in labile blood products: transfusion safety and economic impact].
    Cazenave JP
    Bull Acad Natl Med; 2006 Jan; 190(1):169-85; discussion 186-8. PubMed ID: 16878453
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost-effectiveness of additional hepatitis B virus nucleic acid testing of individual donations or minipools of six donations in the Netherlands.
    Borkent-Raven BA; Janssen MP; van der Poel CL; de Wit GA; Bonsel GJ; van Hout BA
    Transfusion; 2009 Feb; 49(2):311-9. PubMed ID: 19389213
    [TBL] [Abstract][Full Text] [Related]  

  • 13. GB virus type C infection in hemodialysis patients considering co-infection with hepatitis C virus.
    Hosseini-Moghaddam SM; Keyvani H; Samadi M; Alavian SM; Mahdavimazdeh M; Daneshvar S; Razzaghi Z
    J Med Virol; 2008 Jul; 80(7):1260-3. PubMed ID: 18461616
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Prevalence of hepatitis G virus infection (HGV) in intravenous immunoglobulin recipients in the Czech Republic].
    Sobotková M; Bartůnková J; Litzman J; Zachová R; Jílek D; Krystůfková O; Nĕmecek V; Vernerová E; Sedivá A
    Epidemiol Mikrobiol Imunol; 2006 Nov; 55(4):136-9. PubMed ID: 17354588
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protecting the blood supply from emerging pathogens: the role of pathogen inactivation.
    Blajchman MA
    Transfus Clin Biol; 2009 May; 16(2):70-4. PubMed ID: 19427252
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Solvent-detergent viral inactivation of minipools of plasma for transfusion, cryoprecipitate and cryo-poor plasma in single-use bag systems].
    Burnouf T; Goubran HA; Radosevich M; El-Ekiaby M
    Transfus Clin Biol; 2008 Jun; 15(3):129-34. PubMed ID: 18538608
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A pilot study for screening blood donors in Taiwan by nucleic acid amplification technology: detecting occult hepatitis B virus infections and closing the serologic window period for hepatitis C virus.
    Li L; Chen PJ; Chen MH; Chak KF; Lin KS; Tsai SJ
    Transfusion; 2008 Jun; 48(6):1198-206. PubMed ID: 18422856
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current value of serologic test for syphilis as a surrogate marker for blood-borne viral infections among blood donors in the United States.
    Zou S; Notari EP; Fang CT; Stramer SL; Dodd RY
    Transfusion; 2009 Apr; 49(4):655-61. PubMed ID: 19170999
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute hepatitis E virus infection in Taiwan 2002-2006 revisited: PCR shows frequent co-infection with multiple hepatitis viruses.
    Wu KT; Chung KM; Feng IC; Sheu MJ; Kuo HT; Koay LB; Lin CY; Tang LY; Tsai SL
    J Med Virol; 2009 Oct; 81(10):1734-42. PubMed ID: 19697413
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Experience of German Red Cross blood donor services with nucleic acid testing: results of screening more than 30 million blood donations for human immunodeficiency virus-1, hepatitis C virus, and hepatitis B virus.
    Hourfar MK; Jork C; Schottstedt V; Weber-Schehl M; Brixner V; Busch MP; Geusendam G; Gubbe K; Mahnhardt C; Mayr-Wohlfart U; Pichl L; Roth WK; Schmidt M; Seifried E; Wright DJ;
    Transfusion; 2008 Aug; 48(8):1558-66. PubMed ID: 18466173
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.